PCSA · Processa Pharmaceuticals, Inc. · Investor Relations
$1.52
+0.03 (+2.01%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.14M
Shares
2.79M
Volume · Oct 6
18.59K
Avg daily vol (3M)
223.01K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-11 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-07-30 | Annual Meeting of Stockholders | Shareholder meeting |